These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4956461)

  • 1. Mediodespidine: hypotensive reserpoid without sedative effect. I. Comparison of sedative and hypotensive activity in monkeys.
    Trcka V; Dlabac A; Vanĕcek M
    Life Sci; 1965 Dec; 4(23):2257-61. PubMed ID: 4956461
    [No Abstract]   [Full Text] [Related]  

  • 2. Mediodespidine, hypotensive reserpoid without sedative effect. II. Effect on monoamine levels in mouse organs.
    Trcka V; Carlsson A
    Life Sci; 1965 Dec; 4(23):2263-7. PubMed ID: 5880876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Method of trial of antihypertensive agents in cynocephalic monkeys].
    Giono-Barber H; Giono-Barber P
    C R Seances Soc Biol Fil; 1972; 166(12):1810-4. PubMed ID: 4198697
    [No Abstract]   [Full Text] [Related]  

  • 4. Reserpine induced supersensitivity to isoprenaline on the blood pressure and heart rate of anaesthetized rabbits.
    Khatri CK; Qayum A; Yusuf SM
    J Pak Med Assoc; 1976 Jul; 26(7):162-5. PubMed ID: 826663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the central hypotensive effect of alpha-methyldopa by reserpine, imipramine and tranylcypromine.
    Kale AK; Satoskar RS
    Eur J Pharmacol; 1970 Jan; 9(1):120-3. PubMed ID: 5434287
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
    Pals DT; DeGraaf GL
    J Pharmacol Exp Ther; 1985 Feb; 232(2):407-12. PubMed ID: 3968642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reserpine-induced central effects: pharmacological evidence for the lack of central effects of reserpine methiodide.
    Nammi S; Boini KM; Koppula S; Sreemantula S
    Can J Physiol Pharmacol; 2005 Jun; 83(6):509-15. PubMed ID: 16049551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of sedative and hypotensive mechanisms of action of reserpine (serpasil)].
    MALECKI I
    Acta Physiol Pol; 1960; 11():814-5. PubMed ID: 13765740
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of guanethidine and of reserpine on angiotensin responsiveness in man.
    Kállay K; Káldor A; Gachalyi B; Sebestyén
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):35-9. PubMed ID: 1150361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diverse effect of hydrochlorothiazide in relation to the hypotensive activity of reserpine, rescinnamine, syrosingopine, 1, 4-dihydrazino-phthlazine (alone or associated with reserpine), hexamethonium and guanethidine].
    MIELE E; MARMO E; PREZIOSI P
    Arch Ital Sci Farmacol; 1961 Oct; 11():367-70. PubMed ID: 14473573
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of chlorothiazide and hydrochlorothiazide on the hypotensive activity of reserpine].
    PREZIOSI P; MARMO E; MIELE E
    Boll Soc Ital Biol Sper; 1960 Aug; 36():790-4. PubMed ID: 13737927
    [No Abstract]   [Full Text] [Related]  

  • 12. Naloxone reversal of insulin-induced hypotension in reserpine pretreated rats.
    Huidobro-Toro JP; Musacchio JM
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):310-21. PubMed ID: 7283552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the intraventricular administration of some hypotensive drugs on the arterial blood pressure and respiratory movements.
    Cuparencu B; Ticşa I; Csutak V; Safta L; Mocan R
    Acta Biol Med Ger; 1969; 23(6):799-812. PubMed ID: 5375482
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of reserpine and syrosingopine upon pentobarbital depression.
    Ponessa JT; De Boer B
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):67-70. PubMed ID: 4382038
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of reserpine on accommodation and pupil diameter in monkeys (Macaca irus).
    Törnqvist G
    Acta Physiol Scand; 1969 Apr; 75(4):565-7. PubMed ID: 4982623
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the blood pressure effects of reserpine in dogs pretreated with amphetamine or tyramine.
    Yelnosky J; McGill JS; Mastrangelo AS
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):416-23. PubMed ID: 5916744
    [No Abstract]   [Full Text] [Related]  

  • 17. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.
    Hardman HF; Domino EF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):295-315. PubMed ID: 5002533
    [No Abstract]   [Full Text] [Related]  

  • 18. [Observations on the hypertensive action of reserpine].
    Van Proosdij-Hartzema EG
    J Physiol (Paris); 1959; 51(3):551-2. PubMed ID: 13665647
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isolation and pharmacodynamic activity of the sesquiterpene valeranone from Nardostachys jatamansi DC].
    Rücker G; Tautges J; Sieck A; Wenzl H; Graf E
    Arzneimittelforschung; 1978; 28(1):7-13. PubMed ID: 580202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reserpine methonitrate, a novel quaternary analogue of reserpine augments urinary excretion of VMA and 5-HIAA without affecting HVA in rats.
    Sreemantula S; Boini KM; Nammi S
    BMC Pharmacol; 2004 Nov; 4():30. PubMed ID: 15546495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.